Skip to content

Welcome to Discover Pharma! Today is : November 7, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Digital & Data

  • Clinical & Regulatory,Digital & Data,Therapeutic Areas

    Scotland launches accredited Alzheimer’s biomarker testing service

    Scottish Brain Sciences (SBS) has launched an accredited laboratory service [...]

    June 6, 2026
  • Advanced Therapies,Digital & Data,Drug Discovery & Development

    Laverock secures £2.2M to advance AI-powered cell therapy platform

    Laverock Therapeutics has secured more than £2.2 million in grant [...]

    June 6, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Quotient Sciences begins Phase 1 study of AI-designed drug formulation

    Quotient Sciences has begun a Phase 1 clinical study evaluating [...]

    June 6, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Genomics and sequencing

    Countable Labs raises $26m to expand Countable PCR platform

    Countable Labs has raised $26 million in an oversubscribed financing [...]

    June 6, 2026
  • Central Nervous System,Digital & Data,Drug Delivery & Formulation,Drug Discovery & Development,Therapeutic Areas

    Bonito Biosciences partners with DaltonTx on AI-driven RNA delivery research

    Bonito Biosciences has entered a collaboration with DaltonTx to develop [...]

    June 6, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Veristat launches AI biostatistics platform to accelerate clinical trial data readouts

    Veristat has launched an AI-enabled biostatistics platform designed to reduce [...]

    May 15, 2026
  • Biotech & Pharma Business,Digital & Data

    Turning AI Skeptics into AI Advocates Through High-Integrity Data

    With 89% of AI pilots failing to scale, biopharmas can [...]

    May 14, 2026
  • Clinical & Regulatory,Digital & Data,Therapeutic Areas

    Grow Therapy study finds most patients report meaningful improvement in depression and anxiety symptoms

    Grow Therapy has published its first peer-reviewed outcomes study, reporting [...]

    May 14, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Remepy and Merck KGaA partner on hybrid drug programmes

    Remepy has announced a collaboration with Merck KGaA, Darmstadt Germany, [...]

    May 14, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    RxLogix launches AI pharmacovigilance platform for adverse event monitoring

    RxLogix has launched a new version of its PVOne.AI platform [...]

    May 5, 2026
Previous8910Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • BridgeBio gets FDA Priority Review for oral infigratinib in achondroplasia
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • ViiV’s Cabenuva achieves superior viral suppression in CROWN Phase 3b study
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Shift Bioscience publishes AI virtual cell framework for target discovery
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top